Use of dipeptidyl peptidase IV inhibitors as therapeutics for neurological disorders

Details for Australian Patent Application No. 2002328306 (hide)

Owner Probiodrug AG

Inventors Demuth, Hans-Ulrich; Van Horsten, Stephan; Heiser, Ulrich; Glund, Konrad; Hoffmann, Torsten

Agent Watermark

Pub. Number AU-B-2002328306

PCT Number PCT/EP02/07133

PCT Pub. Number WO2003/002596

Priority 101 54 689.0 09.11.01 DE; 01114796.4 27.06.01 EP; 60/360,909 28.02.02 US; 101 50 203.6 12.10.01 DE

Filing date 27 June 2002

Wipo publication date 3 March 2003

Acceptance publication date 6 September 2007

International Classifications

C07K 5/062 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 207/04 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 277/04 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/087 Peptides having up to four amino acids in a fully defined sequence

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 101 54 689.0 09.11.01 DE; 01114796.4 27.06.01 EP; 60/360,909 28.02.02 US; 101 50 203.6 12.10.01 DE

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002328306

6 September 2007 Application Accepted

  Published as AU-B-2002328306

10 January 2008 Standard Patent Sealed

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002328307-A SYSTEM OF ASSISTANCE IN REFEREEING A FOOTBALL MATCH

2002328305-Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis